Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, 695011, India.
Department of Neurosurgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, 695011, India.
IUBMB Life. 2019 Feb;71(2):244-253. doi: 10.1002/iub.1964. Epub 2018 Nov 4.
Sphere formation is an indicator of tumor aggressiveness independent of the tumor grade; however, its relation to progression-free survival (PFS) is less known. This study was designed to assess the neurosphere forming ability among low grade glioma (LGG) and high-grade glioma (HGG), its stem cell marker expression, and correlation to PFS. Tumor samples of 140 patients, including (LGG; n = 67) and (HGG; n = 73) were analyzed. We used sphere forming assay, immunofluorescence, and immunohistochemistry to characterize the tumors. Our study shows that, irrespective of the pathological sub type, both LGG and HGG formed neurospheres in vitro under conventional sphere forming conditions. However, the number of neurospheres formed from tumor tissues were significantly higher in HGG compared to LGG (P < 0.0001). Different grades of glioma were further characterized for the expression of stem cell marker proteins and lineage markers. When neurospheres were analyzed, CD133 positive cells were identified in addition to CD15 and nestin positive cells in both LGG and HGG. When these neurospheres were subjected to differentiation, cells positive for GFAP and β-tubulin III were observed. Expression of stem cell markers and β-tubulin III were prominent in HGG compared to LGG, whereas GFAP expression was higher in LGG than in HGG. Kaplan-Meier survival analysis demonstrated that neurosphere forming ability was significantly associated with shorter PFS (P < 0.05) in both LGG and HGG. Our results supports earlier studies that neurosphere formation may serve as a definitive indicator of stem cell population within the tumor and thus a better predictor of PFS than the tumor grades alone. © 2018 IUBMB Life, 71(1):244-253, 2019.
球体形成是肿瘤侵袭性的指标,与肿瘤分级无关;然而,其与无进展生存期(PFS)的关系尚不清楚。本研究旨在评估低级别胶质瘤(LGG)和高级别胶质瘤(HGG)中的神经球形成能力、其干细胞标志物表达及其与 PFS 的相关性。分析了 140 例患者的肿瘤样本,包括(LGG;n=67)和(HGG;n=73)。我们使用球体形成测定法、免疫荧光和免疫组织化学来对肿瘤进行特征分析。我们的研究表明,无论病理亚型如何,LGG 和 HGG 都可以在传统的球体形成条件下在体外形成神经球。然而,与 LGG 相比,HGG 形成的神经球数量明显更多(P<0.0001)。进一步对不同等级的神经胶质瘤进行了干细胞标志物蛋白和谱系标志物的表达特征分析。当分析神经球时,除了 LGG 和 HGG 中的 CD15 和巢蛋白阳性细胞外,还鉴定出 CD133 阳性细胞。当这些神经球被进行分化时,观察到对 GFAP 和 β-微管蛋白 III 阳性的细胞。与 LGG 相比,HGG 中干细胞标志物和 β-微管蛋白 III 的表达更为显著,而 GFAP 的表达在 LGG 中高于 HGG。Kaplan-Meier 生存分析表明,神经球形成能力与 LGG 和 HGG 的较短 PFS 显著相关(P<0.05)。我们的研究结果支持早期的研究,即神经球形成可能作为肿瘤内干细胞群体的明确指标,因此比肿瘤分级本身更好地预测 PFS。